Feed PKTX
PK

ProtoKinetix, Incorporated

PKTX · OTC

$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $78.3K
P/E Ratio -
Div. Yield -
ROE 116.26%
Piotroski F-Score Weak
2/9
Valuation
94 /100
Cheap
P/B 0.31x
P/S 1.61x
P/FFO N/A
Growth
20 /100
Declining
Book val. growth 1.04%
FCF growth N/A
EPS growth N/A
Profitability
0 /100
Weak
Op. margin 746.74%
Gross margin 28.45%
FCF margin 329.63%
Quality
1 /100
Poor
ROA 78.76%
ROIC 145.16%
Asset turnover 0.10x
Debt
67 /100
Low
Current ratio 0.01x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
61 /100
Moderate
Profitable years 0
Beta 0.73x
EPS volatility 35.37%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about PKTX
Online

Sector

Healthcare

Industry

Biotechnology

CEO

Michael Richard Guzzetta

Employees

5

Headquarters

Dalton

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.